Both in Biotechnology
Outlook Therapeutics vs Black Diamond Therapeutics
Over the past year OTLK returned −64.1% and BDTX returned −54.3%; their daily moves had a correlation of 0.02.
OTLK −64.1% BDTX −54.3%Growth of $1, one year, split-adjusted
| Metric | OTLK | BDTX |
|---|---|---|
| Price | $0.4668 | $1.81 |
| Market cap | $113.6M | $103.7M |
| Today | −0.51% | +3.14% |
| 1 month | −21.6% | −7.0% |
| 6 months | +93.1% | −37.1% |
| Year to date | −70.5% | −25.7% |
| 1 year | −63.0% | −53.4% |
| Revenue growth (YoY) | −99.4% | — |
| Gross margin | −95.0% | — |
| Net margin | −233554.9% | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | -$7.0M | $110.5M |
| Dividend yield | — | — |
| Volatility (60d) | 89.0% | 61.4% |
| Short % of float | 39.3% | 11.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).